Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
UBS
Farmers Insurance
AstraZeneca
US Army
Dow
QuintilesIMS
Boehringer Ingelheim
Baxter

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DEXEDRINE

« Back to Dashboard

Clinical Trials for Dexedrine

Trial ID Title Status Sponsor Phase Summary
NCT00296686 Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression Terminated New York State Psychiatric Institute Phase 4 This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.
NCT00439049 Substance Abuse Pre-Treatment Screening Study Recruiting National Institute on Drug Abuse (NIDA) N/A The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.
NCT00439049 Substance Abuse Pre-Treatment Screening Study Recruiting The University of Texas Health Science Center, Houston N/A The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.
NCT00794625 Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study) Unknown status Northwell Health Phase 4 This study will determine the advantages and disadvantages of adding one of two different types of drugs to stimulant treatment for reducing aggressive behavior in children with attention deficit with hyperactivity disorder (ADHD).
NCT00794625 Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study) Unknown status University of Texas Phase 4 This study will determine the advantages and disadvantages of adding one of two different types of drugs to stimulant treatment for reducing aggressive behavior in children with attention deficit with hyperactivity disorder (ADHD).
NCT00794625 Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study) Unknown status Joseph Blader Phase 4 This study will determine the advantages and disadvantages of adding one of two different types of drugs to stimulant treatment for reducing aggressive behavior in children with attention deficit with hyperactivity disorder (ADHD).
NCT01577706 Spectroscopic Imaging at 4T: A Drug Challenge Study Completed Mclean Hospital N/A An advanced technique for rapid magnetic resonance proton spectroscopic imaging (1H-MRSI) will be employed in a drug challenge study in healthy volunteers to spatially map and measure acute changes in the brain chemicals GABA, glutamate and glutamine after administration of a drug. Three condition will be tested in a double-blind fashion, i)depressant, ii)stimulant, iii)placebo. It is hypothesized that unique and reproducible spatial and directional metabolic response patterns will be observed, unique to each condition within the brain.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Dexedrine

Condition Name

Condition Name for Dexedrine
Intervention Trials
Attention Deficit Hyperactivity Disorder 4
Attention Deficit Hyperactivity Disorder (ADHD) 2
Substance Abuse 1
AOD Effects and Consequences 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dexedrine
Intervention Trials
Hyperkinesis 7
Disease 7
Attention Deficit Disorder with Hyperactivity 7
Cocaine-Related Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dexedrine

Trials by Country

Trials by Country for Dexedrine
Location Trials
United States 10
Canada 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dexedrine
Location Trials
Texas 4
Massachusetts 2
New York 2
Connecticut 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dexedrine

Clinical Trial Phase

Clinical Trial Phase for Dexedrine
Clinical Trial Phase Trials
Phase 4 5
Phase 2 2
Phase 1/Phase 2 1
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dexedrine
Clinical Trial Phase Trials
Recruiting 6
Not yet recruiting 3
Completed 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dexedrine

Sponsor Name

Sponsor Name for Dexedrine
Sponsor Trials
The University of Texas Health Science Center, Houston 3
McGill University Health Center 3
Canadian Institutes of Health Research (CIHR) 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dexedrine
Sponsor Trials
Other 18
NIH 2
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Farmers Insurance
AstraZeneca
Baxter
US Department of Justice
Fish and Richardson
Merck
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.